$4.57
1.56% yesterday
Nasdaq, Aug 12, 10:00 pm CET

Personalis Inc Stock price

$4.57
-1.90 29.37% 1M
-0.09 1.93% 6M
-1.21 20.93% YTD
+0.26 6.03% 1Y
-0.81 15.06% 3Y
-14.44 75.96% 5Y
-12.43 73.12% 10Y
-12.43 73.12% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+0.07 1.56%

Key metrics

Basic
Market capitalization
$399.1m
Enterprise Value
$228.5m
Net debt
positive
Cash
$173.2m
Shares outstanding
88.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
5.0 | 4.7
EV/Sales
2.8 | 2.7
EV/FCF
negative
P/B
2.1
Financial Health
Equity Ratio
75.1%
Return on Equity
-40.1%
ROCE
-31.7%
ROIC
-103.9%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$80.3m | $85.0m
EBITDA
$-61.6m | $-80.7m
EBIT
$-72.0m | $-91.1m
Net Income
$-91.3m | $-85.6m
Free Cash Flow
$-49.2m
Growth (TTM | estimate)
Revenue
0.4% | 0.5%
EBITDA
11.5% | -40.7%
EBIT
11.0% | -33.5%
Net Income
-12.1% | -5.3%
Free Cash Flow
25.2%
Margin (TTM | estimate)
Gross
31.5%
EBITDA
-76.7% | -94.9%
EBIT
-89.6%
Net
-113.7% | -100.7%
Free Cash Flow
-61.2%
More
EPS
$-1.0
FCF per Share
$-0.6
Short interest
11.2%
Employees
229
Rev per Employee
$370.0k
Show more

Is Personalis Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Personalis Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Personalis Inc forecast:

12x Buy
86%
2x Hold
14%

Analyst Opinions

14 Analysts have issued a Personalis Inc forecast:

Buy
86%
Hold
14%

Financial data from Personalis Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
80 80
0% 0%
100%
- Direct Costs 55 55
5% 5%
69%
25 25
14% 14%
31%
- Selling and Administrative Expenses 49 49
4% 4%
61%
- Research and Development Expense 48 48
14% 14%
60%
-62 -62
12% 12%
-77%
- Depreciation and Amortization 10 10
8% 8%
13%
EBIT (Operating Income) EBIT -72 -72
11% 11%
-90%
Net Profit -91 -91
12% 12%
-114%

In millions USD.

Don't miss a Thing! We will send you all news about Personalis Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Personalis Inc Stock News

Neutral
The Motley Fool
7 days ago
Personalis (PSNL) Q2 Revenue Falls 24%
Neutral
Seeking Alpha
7 days ago
Personalis, Inc. (NASDAQ:PSNL ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Aaron L. Tachibana - CFO & COO Christopher M.
Neutral
Business Wire
7 days ago
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the second quarter ended June 30, 2025, and recent accomplishments of its “Win-in-MRD” strategy: Second Quarter 2025 and Recent Business Highlights Clinical Adoption Acceleration: Delivered 3,478 clinical tests in the second quarter, a 59%...
More Personalis Inc News

Company Profile

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA.

Head office United States
CEO Christopher Hall
Employees 229
Founded 2011
Website www.personalis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today